These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 10803728)

  • 1. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ; Lamberts SW; van Hagen PM; Reubi JC; Schaeffer J; Waaijers M; van Koetsveld PM; Srinivasan A; Krenning EP; Breeman WA
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.
    Vaidyanathan G; Friedman HS; Affleck DJ; Schottelius M; Wester HJ; Zalutsky MR
    Clin Cancer Res; 2003 May; 9(5):1868-76. PubMed ID: 12738745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivo.
    Schottelius M; Reubi JC; Eltschinger V; Schwaiger M; Wester HJ
    J Med Chem; 2005 Apr; 48(8):2778-89. PubMed ID: 15828816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu.
    Konijnenberg MW; Bijster M; Krenning EP; De Jong M
    J Nucl Med; 2004 Jul; 45(7):1260-9. PubMed ID: 15235075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation dosimetry for indium-111-pentetreotide.
    Stabin MG; Kooij PP; Bakker WH; Inoue T; Endo K; Coveney J; de Jong R; Minegishi A
    J Nucl Med; 1997 Dec; 38(12):1919-22. PubMed ID: 9430470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
    Schluep T; Cheng J; Khin KT; Davis ME
    Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of two octreotate analogs radiolabeled with indium and yttrium in rats.
    Laznickova A; Laznicek M; Trejtnar F; Maecke HR; Eisenwiener KP; Reubi JC
    Anticancer Res; 2010 Jun; 30(6):2177-84. PubMed ID: 20651367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
    Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
    J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
    Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
    Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacokinetics of the antitumor preparation of dimetinur].
    Ostrovskaia LA; Rykova VA; Konradov AA; Ivanov AS; Korman DB
    Eksp Onkol; 1989; 11(2):57-62. PubMed ID: 2737132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of hapten-peptide labeling for pretargeted immunoPET of bispecific antibody using generator-produced 68Ga.
    Karacay H; Sharkey RM; McBride WJ; Rossi EA; Chang CH; Goldenberg DM
    J Nucl Med; 2011 Apr; 52(4):555-9. PubMed ID: 21421724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extension of Satterthwaite's approximation applied to pharmacokinetics.
    Nedelman JR; Jia X
    J Biopharm Stat; 1998 May; 8(2):317-28. PubMed ID: 9598425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Approaches for Modeling Radiopharmaceutical Pharmacokinetics Using Continuous Distributions of Rates.
    Shuryak I; Dadachova E
    J Nucl Med; 2015 Oct; 56(10):1622-8. PubMed ID: 26205297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Averaging pharmacokinetic parameter estimates from experimental studies: statistical theory and application.
    Roe DJ; Karol MD
    J Pharm Sci; 1997 May; 86(5):621-4. PubMed ID: 9145389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing for the equality of area under the curves when using destructive measurement techniques.
    Bailer AJ
    J Pharmacokinet Biopharm; 1988 Jun; 16(3):303-9. PubMed ID: 3221328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond IC
    Beam A; Motsinger-Reif A
    J Pharmacogenomics Pharmacoproteomics; 2014 Mar; 5(1):1000121. PubMed ID: 25110614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A robust summarize-regress procedure for tissue-specific pharmacokinetics.
    Mayo MS; Buchsbaum DJ
    J Biopharm Stat; 2000 May; 10(2):251-64. PubMed ID: 10803728
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.